
Fine particles between one and five microns ensure optimal alveolar deposition, crucial for treating chronic lower respiratory tract diseases.
Higher output speeds reduce treatment duration, increasing patient throughput and clinical efficiency in high-volume emergency or pediatric wards.
Reducing wasted medication ensures precise dosing and cost-effectiveness, particularly vital when administering expensive specialized pulmonary pharmacological agents.
Robust materials must withstand repeated autoclave cycles or chemical sterilization to prevent cross-contamination in sensitive clinical environments.
